How to Reconstitute Peptides: A Research-Procedure Explainer
Direct answer
Peptide reconstitution is the laboratory step of dissolving a lyophilized (freeze-dried) peptide powder back into a liquid using a sterile diluent — most commonly bacteriostatic water — and then calculating the resulting concentration. As a research procedure it has three parts: choosing a diluent suited to the peptide's solubility, adding a measured volume of liquid to the powder and letting it dissolve gently, and computing concentration as milligrams of peptide ÷ milliliters of diluent. This page describes that procedure as research and educational information, not medical advice, and not an instruction to prepare anything for human use. Most so-called "research peptides" are not FDA-approved and are sold "research use only — not for human consumption." Peptevity sells nothing and publishes no human-dosing protocols. The calculator spec below is a research-math utility, framed the same way.
What "reconstitution" means, and the framing this page holds
In the laboratory, most research peptides are shipped as a lyophilized powder — freeze-dried to remove water, because the dry solid is far more stable for storage and shipping than a solution (Practical advice on lyophilized protein drug products, 2024, PMC11744310). "Reconstitution" is simply the reverse step: returning that powder to a liquid with a measured volume of sterile diluent so its concentration is known.
We describe this as a bench/laboratory procedure only. This page is part of our reconstitution and storage how-to silo, the highest-scrutiny section on Peptevity, and the rule here is fixed: we explain the chemistry and the math, and we do not publish human-dosing protocols or self-administration instructions. The compounds people search this term for are, in nearly every case, not FDA-approved and are sold under a "research use only" label — see what "research use only" means and whether peptides are legal. Where a claim touches efficacy or safety, we grade it per our evidence-grading methodology; the procedural facts below are sourced to manufacturer technical notes, peer-reviewed reviews, and FDA labeling.
The procedure, as a laboratory technique
1. Match the diluent to the peptide's solubility
A peptide's solubility is governed mainly by its sequence — its polarity, set by the balance of charged versus hydrophobic residues. Manufacturer guidance is consistent: peptides rich in charged (hydrophilic) residues generally dissolve in water or aqueous buffer, whereas highly hydrophobic or neutral peptides may be only partly soluble in water and are better dissolved first in a small amount of an organic solvent (DMSO, acetonitrile, or an alcohol); basic peptides can be taken up first in a little dilute acid and acidic peptides in a little dilute base, before diluting out (Bachem, peptide solubility technical note). Bachem's own advice is to test solubility on a small aliquot first rather than committing the whole sample (Bachem).
For aqueous-soluble peptides, the common laboratory diluent is bacteriostatic water — sterile water containing 0.9% benzyl alcohol as an antimicrobial preservative, which allows a multi-use vial to resist microbial growth (DailyMed label). Benzyl alcohol is not inert, however: in protein and peptide formulation it can promote aggregation through interaction with nonpolar side chains, which is one reason highly hydrophobic peptides are handled differently (Factors affecting peptide aggregation, 2017, PMC5665799). We cover the diluent itself in more depth on the bacteriostatic water explainer.
2. Add a measured volume and let it dissolve gently
The mechanics are deliberately unhurried. In a laboratory the diluent is directed against the glass wall of the vial rather than blasted onto the powder, and the vial is swirled — not shaken — until the solution is clear. Vigorous agitation introduces shear and air–liquid interfacial stress, both of which are recognized drivers of peptide and protein aggregation during reconstitution (PMC5665799; PMC11744310). A cloudy or incompletely dissolved solution signals a solubility mismatch — the cue to revisit step 1, not to force it.
3. Compute the concentration (the math)
This is the part the calculator below automates. The arithmetic is simple division:
- Concentration (mg/mL) = peptide mass (mg) ÷ diluent volume (mL). Example: 5 mg of peptide reconstituted in 2 mL of diluent → 2.5 mg/mL.
- To express that per microliter for bench work: 2.5 mg/mL = 2.5 mg per 1,000 µL = 0.0025 mg/µL (i.e., 2.5 µg/µL).
- To find the volume that contains a target mass (a research-math operation, e.g., for an in-vitro working aliquot): volume (mL) = target mass (mg) ÷ concentration (mg/mL).
A widely used convention on the research-chemical bench is the insulin-syringe "unit": a U-100 syringe has 100 units per 1 mL, so each unit = 0.01 mL. We present that conversion only as arithmetic for measuring a laboratory volume, never as a dosing instruction. For worked tables across common vial sizes, see the companion peptide reconstitution chart; the dedicated peptide calculator tool will live on its own page.
Stability and storage, in brief
Reconstitution starts a clock. Once a peptide is in solution it is less stable than the dry powder, and the relevant variables are temperature, light, and time (PMC5665799). General laboratory practice keeps reconstituted peptide refrigerated and the lyophilized powder frozen; the benzyl alcohol in bacteriostatic water is what makes a multi-use vial practical without microbial overgrowth, but it does not make the peptide itself chemically immortal. The full handling discussion lives on how to store peptides. None of this is a shelf-life guarantee for human use, which is outside this page's scope.
The reconstitution calculator — build spec (research-math utility)
The following is a specification for the development build of an ad-free, client-side calculator — not a live widget on this page. It is framed identically to the rest of this silo: a research-math utility that performs unit conversions, not a dosing tool. The sibling peptide calculator term gets its own dedicated page; this spec is the shared logic.
Inputs
| Field | Type | Unit | Validation |
|---|---|---|---|
| Peptide mass | number | mg | > 0; required |
| Diluent volume (bacteriostatic water) | number | mL | > 0; required |
| Target amount (optional) | number | mg or µg (toggle) | ≥ 0; optional |
Outputs
- Concentration:
peptide_mg / diluent_mL→ displayed as mg/mL and mg/µL (and µg/µL). - Volume for target amount (only if Target amount provided):
target_mg / concentration_mg_per_mL→ displayed as mL, µL, and U-100 insulin-syringe units (mL × 100), each clearly labeled "laboratory volume — not a dose."
Calculation logic (pseudocode)
concentration_mg_per_mL = peptide_mg / diluent_mL // core formula
concentration_mg_per_uL = concentration_mg_per_mL / 1000
if target provided:
target_mg = (unit == "µg") ? target_input / 1000 : target_input
volume_mL = target_mg / concentration_mg_per_mL
volume_uL = volume_mL * 1000
units_u100 = volume_mL * 100 // 1 unit = 0.01 mL
Edge cases: divide-by-zero guarded (volume or mass = 0 → inline message, no result); negative/non-numeric inputs rejected before calc; round display to 4 significant figures; never auto-fill any field with a "suggested" mass or dose.
Required UI copy (verbatim, non-dismissible)
- Header microcopy: "Research-math utility. Converts mass and volume into concentration. It does not recommend, calculate, or imply any human dose."
- Standing banner (top of widget): "Research and educational information, not medical advice. The compounds discussed are typically not FDA-approved and are sold 'research use only — not for human consumption.' Peptevity sells nothing." with a link to the 2026 regulatory tracker.
- Output caption: "Outputs are laboratory volumes and concentrations, not doses."
- No defaults, no presets named after a compound's 'typical dose,' no purchase links, no vendor names, no ads. (Firewall: zero products, zero affiliate links — see our conflict-of-interest and funding statement.)
Build constraints
Client-side only (no input logged or transmitted); self-hosted, no third-party analytics on the tool; keyboard-accessible; renders a static fallback table (the reconstitution chart) if JavaScript is disabled.
Honest bottom line
Strip it down and reconstitution is dilution arithmetic applied to a freeze-dried powder — choose a compatible diluent, add a measured volume, swirl until clear, and divide milligrams by milliliters. Those facts are sourced to manufacturer technical notes, peer-reviewed formulation reviews, and FDA labeling, and they describe a laboratory technique. What this page deliberately does not do is tell anyone to prepare a peptide for their own body: the compounds in question are largely not FDA-approved, are sold "research use only — not for human consumption," and sit in a regulatory picture that is actively shifting through 2026 and into 2027. If you take one thing from this page, take the line between the chemistry (well defined) and the use (not something we instruct). For the dated status, watch the living 2026 regulatory tracker.
Frequently asked questions
What does it mean to reconstitute a peptide? Reconstitution is the laboratory step of dissolving a lyophilized (freeze-dried) peptide powder back into a liquid using a measured volume of sterile diluent, so the resulting concentration is known (PMC11744310). Peptides are shipped dry because the solid form is more stable for storage and transport. This is a bench technique; it is research and educational information, not medical advice, and not an instruction to prepare anything for human use.
What liquid is used to reconstitute peptides in the lab? For water-soluble peptides, the common diluent is bacteriostatic water — sterile water with 0.9% benzyl alcohol as a preservative, which lets a multi-use vial resist microbial growth (DailyMed). Highly hydrophobic peptides are often dissolved first in a small amount of an organic solvent or dilute acid, then diluted (Bachem). Benzyl alcohol is labeled "not for use in neonates" because of its association with fatal "gasping syndrome" in newborns (NEJM, 1982).
How is peptide concentration calculated? Concentration in mg/mL equals the peptide mass in milligrams divided by the diluent volume in milliliters — for example, 5 mg in 2 mL is 2.5 mg/mL. To find the volume containing a target mass, divide the target mass by the concentration. These are unit conversions for measuring laboratory volumes, not dose calculations.
Why swirl instead of shake the vial? Vigorous shaking introduces shear and air–liquid interfacial stress, both recognized drivers of peptide and protein aggregation; gentle swirling against the vial wall avoids that (PMC5665799). A cloudy solution indicates a solubility mismatch rather than a mixing problem.
Are reconstituted research peptides legal or FDA-approved? The compounds usually involved (BPC-157, TB-500, GHK-Cu, MOTS-c, and others) are not FDA-approved for any use. In April 2026 the FDA removed a group of such peptides from its interim 503A Category 2 list because the supporting nominations were withdrawn — removal is not approval — and a PCAC meeting on July 23–24, 2026 is reviewing whether to add seven (BPC-157, TB-500, KPV, MOTS-c, DSIP, epitalon, Semax) to the 503A bulks list, with a second review group (including GHK-Cu and Melanotan II) expected before the end of February 2027 (Federal Register, docket FDA-2025-N-6895). Material is typically sold "research use only — not for human consumption." See the dated 2026 regulatory tracker.
How we graded this page
This is a procedural/laboratory explainer, not an efficacy claim. Every chemistry, stability, and regulatory statement is tied to a primary or manufacturer/regulator source per our evidence-grading methodology and sourcing and citation policy. Peptevity carries no advertising, no affiliate links, and sells nothing — see our conflict-of-interest and funding statement, and our medical disclaimer and RUO statement.
References
- Bachem. Peptide Solubility — Technical Note. https://www.bachem.com/knowledge-center/technical-notes/peptide-solubility/
- Practical advice in the development of a lyophilized protein drug product. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11744310/
- Factors affecting the physical stability (aggregation) of peptide therapeutics. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC5665799/
- DailyMed / U.S. FDA. Bacteriostatic Water for Injection, USP (0.9% benzyl alcohol) label. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ccadcf46-6a6f-436b-9bbc-17e2983a335f
- Gershanik J, et al. The Gasping Syndrome and Benzyl Alcohol Poisoning. N Engl J Med. 1982. https://www.nejm.org/doi/abs/10.1056/NEJM198211253072206
- U.S. FDA. Bulk Drug Substances Used in Compounding Under Section 503A. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act
- Federal Register / U.S. FDA. Pharmacy Compounding Advisory Committee — Notice of Meeting (July 23–24, 2026); docket FDA-2025-N-6895. https://www.federalregister.gov/documents/2026/04/16/2026-07361/pharmacy-compounding-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request
Related on Peptevity
- Reconstitution and storage how-to hub — the full procedural silo (research framing).
- The peptide calculator — the interactive research-math tool (own page).
- Peptide reconstitution chart — worked concentration tables.
- How to store peptides — temperature, light, and time.
- Bacteriostatic water explained — the diluent and its benzyl alcohol preservative.
- What "research use only" means — the RUO label, explained.
- The 2026 regulatory tracker — dated FDA / 503A status.
- How Peptevity grades evidence — the evidence scale behind every claim.
External references appear as citations only; none of the cited institutions endorse, review, or are affiliated with Peptevity.
Every claim above is cited inline to a primary source. See how we grade evidence and our sourcing & citation policy.